The Current State of Targeted Agents in Rectal Cancer

by Dae Dong Kim, Cathy Eng
Published 2012-01-01

418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastat...

by Filip Janku, Matthew Taylor, Michael Gordon, Cathy Eng, Antonio Jimeno, Joaquina Baranda, Ursula Matulonis, Martin Kornacker, Asha Kamat, Oliver Rosen
Published 2020-11-01

The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.

by Christopher H Lieu, Hai Tran, Zhi-Qin Jiang, Muling Mao, Michael J Overman, E Lin, Cathy Eng, Jeffrey Morris, Lee Ellis, John V Heymach, Scott Kopetz
Published 2013-01-01

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery

by Marc Uemura, Wei Qiao, Keith Fournier, Jeffrey Morris, Paul Mansfield, Cathy Eng, Richard E Royal, Robert A Wolff, Kanwal Raghav, Gary N Mann, Michael J Overman
Published 2017-05-01

Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

by Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, Bryan Kee, David Fogelman, Eduardo Vilar, Imad Shureiqi, Kanwal Raghav, Cathy Eng, Shanequa Manuel, Shadarra Crosby, Robert A Wolff, Kimberly Banks, Richard Lanman, AmirAli Talasaz, Scott Kopetz, Van Morris
Published 2017-01-01

Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients

by Nina D. Arhin, Chan Shen, Christina E. Bailey, Lea K. Matsuoka, Alexander T. Hawkins, Andreana N. Holowatyj, Kristen K. Ciombor, Michael B. Hopkins, Timothy M. Geiger, Audrey E. Kam, Marc T. Roth, Cody M. Lebeck Lee, Michael Lapelusa, Arvind Dasari, Cathy Eng
Published 2021-07-01

Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.

by Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, Ganiraju Manyam, Bryan K Kee, David R Fogelman, Arvind Dasari, Kanwal Raghav, Eduardo Vilar, Shanequa Manuel, Imad Shureiqi, Robert A Wolff, Keyur P Patel, Raja Luthra, Kenna Shaw, Cathy Eng, Dipen M Maru, Mark J Routbort, Funda Meric-Bernstam, Scott Kopetz
Published 2017-01-01

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation

by Garrett Jensen, MD, Randa Tao, MD, Cathy Eng, MD, John M. Skibber, MD, Miguel Rodriguez-Bigas, MD, George J. Chang, MD, Y. Nancy You, MD, Brian K. Bednarski, MD, Bruce D. Minsky, MD, Eugene Koay, MD, PhD, Cullen Taniguchi, MD, PhD, Sunil Krishnan, MD, Prajnan Das, MD, MS, MPH
Published 2018-10-01

Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.

by Mala Pande, Aron Joon, Abenaa M Brewster, Wei V Chen, John L Hopper, Cathy Eng, Sanjay Shete, Graham Casey, Fredrick Schumacher, Yi Lin, Tabitha A Harrison, Emily White, Habibul Ahsan, Irene L Andrulis, Alice S Whittemore, Esther M John, Aung Ko Win, Enes Makalic, Daniel F Schmidt, Miroslaw K Kapuscinski, Heather M Ochs-Balcom, Steven Gallinger, Mark A Jenkins, Polly A Newcomb, Noralane M Lindor, Ulrike Peters, Christopher I Amos, Patrick M Lynch
Published 2018-01-01

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis

by Jillian R. Gunther, MD, PhD, Awalpreet S. Chadha, MD, Ui Sup Shin, MD, In Ja Park, MD, Kiran V. Kattepogu, MD, Jonathan D. Grant, MD, David C. Weksberg, MD, PhD, Cathy Eng, MD, Scott E. Kopetz, MD, PhD, Prajnan Das, MD, MS, MPH, Marc E. Delclos, MD, Harmeet Kaur, MD, Dipen M. Maru, MD, John M. Skibber, MD, Miguel A. Rodriguez-Bigas, MD, Y. Nancy You, MD, Sunil Krishnan, MD, George J. Chang, MD, MS
Published 2017-07-01